Pharmacokinetics and Exposure-Response Relationship of Belimumab Administered Subcutaneously to SLE Patients

被引：0
|
作者：
Struemper, Herbert [1 ]
Thapar, Mita [2 ]
Gordon, David [3 ]
Roth, David [3 ]
机构：
[1] PAREXEL, Quantitat Clin Dev, Durham, NC USA
[2] ICON, Marlow, Bucks, England
[3] GSK, Philadelphia, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics, Pharmacodynamics and Exposure-Response Analyses of Ocrelizumab in Patients With Multiple Sclerosis
    Kletzl, Heidemarie
    Gibiansky, Ekaterina
    Petry, Claire
    Mercier, Francois
    Guenther, Andreas
    Wang, Qing
    Model, Fabian
    Kappos, Ludwig
    Hauser, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [22] Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients With Severe Asthma
    Kotani, Naoki
    Dolton, Michael
    Svensson, Robin J.
    Ribbing, Jakob
    Friberg, Lena E.
    Vadhavkar, Shweta
    Cheung, Dorothy
    Staton, Tracy
    Sperinde, Gizette
    Jin, Jin
    Putnam, Wendy S.
    Quartino, Angelica
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (07): : 905 - 917
  • [23] Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes
    Petri, Kristin C. C.
    Hale, Paula M.
    Hofman, Paul L.
    Jacobsen, Lisbeth, V
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (10): : 1289 - 1292
  • [24] Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
    Ryuji Kubota
    Kazuya Fukumura
    Toshihiro Wajima
    Pharmaceutical Research, 2018, 35
  • [25] Population Pharmacokinetics, Efficacy Exposure-Response Analysis
    Chan, Phyllis
    Yu, Jiajie
    Chinn, Leslie
    Prohn, Marita
    Huisman, Jan
    Matzuka, Brett
    Hanley, William
    Tuckwell, Katie
    Quartino, Angelica
    PHARMACEUTICAL RESEARCH, 2020, 37 (02)
  • [26] Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
    Kubota, Ryuji
    Fukumura, Kazuya
    Wajima, Toshihiro
    PHARMACEUTICAL RESEARCH, 2018, 35 (11)
  • [27] Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
    Ponce-Bobadilla, Ana Victoria
    Stodtmann, Sven
    Eckert, Doerthe
    Zhou, Wen
    Liu, Wei
    Mohamed, Mohamed-Eslam F.
    CLINICAL PHARMACOKINETICS, 2023, 62 (01) : 101 - 112
  • [28] Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica
    Xu, Christine
    Denney, William S.
    Liu, Ying
    Sloane, Jennifer
    Diab, Remco
    Abdallah, Hisham
    Macha, Sreeraj
    Dasgupta, Bhaskar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [29] ONSET AND DURABILITY OF EFFICACY OF BELIMUMAB ADMINISTERED SUBCUTANEOUSLY PLUS STANDARD OF CARE MEDICATIONS TO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A PHASE III TRIAL
    Doria, A.
    Stohl, W.
    Schwarting, A.
    Hammer, A.
    Fox, N. I.
    Groark, J.
    Bass, D.
    Pobiner, B.
    Edwards, L.
    Eastman, W.
    Gordon, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S13 - S13
  • [30] Exposure-response relationship of regorafenib efficacy in patients with hepatocellular carcinoma
    Solms, Alexander
    Reinecke, Isabel
    Fiala-Buskies, Sabine
    Keunecke, Anne
    Drenth, Henk-Jan
    Bruix, Jordi
    Meinhardt, Gerold
    Cleton, Adriaan
    Ploeger, Bart
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : S149 - S153
12345